271 related articles for article (PubMed ID: 23457048)
1. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.
Kershaw G; Orellana D
Semin Thromb Hemost; 2013 Apr; 39(3):283-90. PubMed ID: 23457048
[TBL] [Abstract][Full Text] [Related]
2. The laboratory diagnosis of lupus anticoagulants.
Lazarchick J; Kizer J
Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
[TBL] [Abstract][Full Text] [Related]
3. Performance and Interpretation of Mixing Tests in Coagulation.
Kershaw G
Methods Mol Biol; 2017; 1646():85-90. PubMed ID: 28804820
[TBL] [Abstract][Full Text] [Related]
4. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
[TBL] [Abstract][Full Text] [Related]
5. [Mixing test for prolonged clotting time: clinical availability and problems].
Uchiba M; Ando Y
Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
[TBL] [Abstract][Full Text] [Related]
6. Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.
Benzon HT; Park M; McCarthy RJ; Kendall MC; Lindholm PF
Anesth Analg; 2019 Jun; 128(6):1089-1096. PubMed ID: 31094773
[TBL] [Abstract][Full Text] [Related]
7. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
Brandt JT; Triplett DA; Musgrave K; Orr C
Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
[TBL] [Abstract][Full Text] [Related]
9. [Interpretation of screening tests of hemostasis].
Wuillemin WA; Heizmann M
Praxis (Bern 1994); 2003 Jan; 92(3):57-64. PubMed ID: 12577721
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
Hong SK; Hwang SM; Kim JE; Kim HK
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
[TBL] [Abstract][Full Text] [Related]
11. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
Kamal AH; Tefferi A; Pruthi RK
Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
[TBL] [Abstract][Full Text] [Related]
12. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
Moore GW; Savidge GF
Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
[TBL] [Abstract][Full Text] [Related]
13. Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants.
Devreese KM
Thromb Res; 2007; 119(3):369-76. PubMed ID: 16704874
[TBL] [Abstract][Full Text] [Related]
14. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
Al-Mondhiry H; Galanakis D
J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
[TBL] [Abstract][Full Text] [Related]
15. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
16. The laboratory heterogeneity of lupus anticoagulants.
Triplett DA; Brandt JT; Maas RL
Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
[TBL] [Abstract][Full Text] [Related]
17. Activated partial thromboplastin time: new tricks for an old dogma.
Lippi G; Favaloro EJ
Semin Thromb Hemost; 2008 Oct; 34(7):604-11. PubMed ID: 19085761
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.
Chen J; Phillips B; Chandler WL
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):90-6. PubMed ID: 26397883
[TBL] [Abstract][Full Text] [Related]
19. A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Hazim AZ; Ruan GJ; Khodadadi RB; Slusser JP; Marshall AL; Pruthi RK
Int J Lab Hematol; 2022 Feb; 44(1):209-215. PubMed ID: 34612006
[TBL] [Abstract][Full Text] [Related]
20. [Interpretation of hemostatic and fibrinolytic markers].
Asakura H
Rinsho Byori; 2011 Oct; 59(10):970-7. PubMed ID: 22184880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
